Canada markets close in 13 minutes

Galectin Therapeutics Inc. (GALT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.4400-0.0600 (-1.71%)
As of 03:47PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
32,130
32,130
31,737
23,818
17,976
Selling General and Administrative
5,942
5,942
6,615
6,361
5,468
Total Operating Expenses
38,072
38,072
38,352
30,179
23,444
Operating Income or Loss
-38,072
-38,072
-38,352
-30,179
-23,444
Interest Expense
2,792
2,792
1,033
489
87
Total Other Income/Expenses Net
-432
-432
557
138
-
Income Before Tax
-41,066
-41,066
-38,776
-30,527
-23,465
Income from Continuing Operations
-41,066
-41,066
-38,776
-30,527
-23,465
Net Income
-41,066
-41,066
-38,776
-30,527
-23,465
Net Income available to common shareholders
-44,805
-44,805
-38,873
-30,698
-23,602
Basic EPS
-0.39
-0.74
-0.65
-0.52
-0.41
Diluted EPS
-0.39
-0.74
-0.65
-0.52
-0.41
Basic Average Shares
52,238
60,159
59,391
58,527
57,029
Diluted Average Shares
52,238
60,159
59,391
58,527
57,029